This likely results from: Reduced mechanical stress from weight loss decreasing load on joints Lower systemic inflammation reducing inflammatory mediators in joint tissue Improved metabolic health reducing the metabolic component of osteoarthritis While there are no large randomized trials specifically studying semaglutide for osteoarthritis, the clinical observations are consistent and encouraging
doi: 10.1159/000534725, 28
4 Month Kit Includes medication & supply
(PubMed) Xiang G, Pu J, Yue L, Hou J, Sun H
Exenatide, MedlinePlus (2021) Dulaglutide, MedlinePlus (2023) Obesity in adolescents, The New England Journal of Medicine (2023) Nutrition and pubertal development, Indian Journal of Endocrinology and Metabolism (2014) GLP-1 receptor agonists and eating disorders, National Eating Disorder Association (n.d.) Facts about falls, Centers for Disease Control and Prevention (2024) Hypoglycemia in older people a less well recognized risk factor for frailty, Aging and Disease (2015) Ozempic, Novo Nordisk Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Strengths and Substitutes Currently, Obesema injections are available only in a strength of 1.7 mg of Semaglutide